Pargolol

{{Chembox

| ImageFile = Pargolol.svg

| ImageSize = 200px

| ImageAlt =

| IUPACName = 1-(tert-Butylamino)-3-(2-prop-2-ynoxyphenoxy)propan-2-ol

| OtherNames =

|Section1={{Chembox Identifiers

| CASNo = 47082-97-3

| CASNo_Ref = {{cascite|correct|CAS}}

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 5OPO851W5L

| PubChem = 68673

| ChemSpiderID = 61927

| SMILES = CC(C)(C)NCC(COC1=CC=CC=C1OCC#C)O

| InChI = 1/C16H23NO3/c1-5-10-19-14-8-6-7-9-15(14)20-12-13(18)11-17-16(2,3)4/h1,6-9,13,17-18H,10-12H2,2-4H3

| InChIKey = UFNAECVCKNHAKN-UHFFFAOYAZ

| StdInChI = 1S/C16H23NO3/c1-5-10-19-14-8-6-7-9-15(14)20-12-13(18)11-17-16(2,3)4/h1,6-9,13,17-18H,10-12H2,2-4H3

| StdInChIKey = UFNAECVCKNHAKN-UHFFFAOYSA-N

}}

|Section2={{Chembox Properties

| C=16 | H=23 | N=1 | O=3

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility = }}

|Section3={{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt = }}

}}

Pargolol is a beta adrenergic receptor antagonist.{{cite journal|pmid=6110251|year=1980|last1=Hugues|first1=FC|last2=Julien|first2=D|last3=Bors|first3=V|last4=Mougeot|first4=G|last5=Marche|first5=J|title=Determination in man of the beta blocking properties and the pharmacological half of pargolol (Author's transl)|volume=35|issue=4|pages=475–81|journal=Thérapie}}